Zaf Qasim examines the UK-REBOA trial results presented at the 2023 Critical Care Reviews meeting. This early commentary considers the signal of harm, differences between patient groups, delays to bleeding control and the role of experience and systems of care.
Highlights from the final day of the Intensive Care Society's 2023 State of the Art Congress. Topics include traumatic brain injury, ethics and end-of-life care, alongside a debate on rehabilitation and supporting patients after critical illness.
Day two of the Intensive Care Society's 2023 State of the Art Congress brings research updates on kidneys, the gut and airway management. The report also covers patient communication, acute respiratory distress syndrome, debriefing, trauma and trainee-led research.
A report from the opening day of the Intensive Care Society's 2023 State of the Art conference in Birmingham. It covers ultrasound workshops, workforce and training challenges, respiratory physiology, ICU design, liver failure and patients' experiences of delirium.
A critical appraisal of the DEVICE trial comparing video and direct laryngoscopy in critically ill adults. It examines the improvement in first-attempt intubation success, the absence of a clear difference in severe complications, and how operator experience and patient selection affect interpretation.
What does the PATCH trial tell us about tranexamic acid in major trauma? This appraisal examines the distinction between survival and favourable functional recovery at six months, and why the choice of outcome matters when interpreting the trial.
Practical perspectives on trauma care and team leadership.
Explore the series →